LabCorp

empresa de laboratório clínico

8membros1here now

Pergunte ao Genius Site

LabCorp· Finance · 37 sources · Sep 28, 2026Story

Cornell Reopens 2024 Sexual Assault Case

A suspect turned himself in after a shooting at Eddy Street Commons, while Indiana’s unemployment rate fell to 3.3%. Other reported developments included the reopening of a Cornell sexual-assault case, storm damage in New England, pandas arriving in Atlanta, a multistate Labcorp settlement, and weaker rural business conditions amid higher fuel and fertilizer costs.

Finance· Sep 28, 2026

0

LabCorp· Business · 36 sources · Jul 23, 2026Story

Quest Diagnostics Beats Q2 Revenue, Raises Forecast

Quest Diagnostics posted Q2 2026 revenue of $3.04 billion, up 10.2% and delivering adjusted EPS of $3.12, beating expectations, and it raised its full-year outlook to roughly $11.95–$12.05 billion in revenue and $11.05–$11.25 per share in adjusted earnings amid strong demand across physician, hospital and consumer channels. The results signal sustained demand and positive momentum for diagnostic testing services, with revenue-per-requisition dynamics and volumes supporting the upgrade to guidance.

Business· Jul 23, 2026

0

LabCorp

empresa de laboratório clínico

8membros1here now

Pergunte ao Genius Site

LabCorp· Finance · 37 sources · Sep 28, 2026Story

Cornell Reopens 2024 Sexual Assault Case

A suspect turned himself in after a shooting at Eddy Street Commons, while Indiana’s unemployment rate fell to 3.3%. Other reported developments included the reopening of a Cornell sexual-assault case, storm damage in New England, pandas arriving in Atlanta, a multistate Labcorp settlement, and weaker rural business conditions amid higher fuel and fertilizer costs.

Finance· Sep 28, 2026

0

LabCorp· Business · 36 sources · Jul 23, 2026Story

Quest Diagnostics Beats Q2 Revenue, Raises Forecast

Quest Diagnostics posted Q2 2026 revenue of $3.04 billion, up 10.2% and delivering adjusted EPS of $3.12, beating expectations, and it raised its full-year outlook to roughly $11.95–$12.05 billion in revenue and $11.05–$11.25 per share in adjusted earnings amid strong demand across physician, hospital and consumer channels. The results signal sustained demand and positive momentum for diagnostic testing services, with revenue-per-requisition dynamics and volumes supporting the upgrade to guidance.

Business· Jul 23, 2026